SCHEMBL4682261

SCHEMBL4682261

CCC(C1CC(n2cnc3ccccc32)CCN1C(=O)O)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.44
▸ SLC6A4 P31645 1/20 0.44
▸ KMT2A Q03164 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ IDO1 P14902 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ TACR2 P21452 1/20 0.38
▸ OPRM1 P35372 1/20 0.38
▸ OPRL1 P41146 1/20 0.38
▸ CCR5 P51681 2/20 0.38
▸ PKM P14618 2/20 0.37
▸ FPR2 P25090 1/20 0.36
▸ AGER Q15109 1/20 0.36
▸ TPSAB1 Q15661 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4674480 0.84 ALDH1A1 (0.44) KMT2AALDH1A1USP2CCR5HSD17B10
SCHEMBL4682266 0.83 DRD2 (0.43) DRD2SLC6A4KMT2AALDH1A1USP2
SCHEMBL4682269 0.83 DRD2 (0.43) DRD2SLC6A4KMT2AALDH1A1USP2
SCHEMBL4678001 0.80 FPR2 (0.42) CYP2C9OPRM1CCR5FPR2
SCHEMBL4675596 0.79 CYP3A4 (0.40) DRD2SLC6A4OPRM1OPRL1CHRM2
SCHEMBL4676160 0.78 HSD11B1 (0.45) KMT2AALDH1A1CHRM1
SCHEMBL3803735 0.78 OPRM1 (0.49) ALDH1A1CYP2C9OPRM1OPRL1CHRM2
SCHEMBL4674536 0.76 PTGDR2 (0.35) OPRM1OPRL1CHRM2CHRM1CHRM3
SCHEMBL4681956 0.76 OPRL1 (0.48) OPRM1OPRL1
SCHEMBL1838649 0.75 DRD2 (0.41) DRD2SLC6A4KMT2AALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1997805-A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans Commissariat à l'Energie Atomique (FR) 2008-12-03 — — EP disclosed
Send feedback